Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development - Seite 3

To learn more about VeriSIM Life Translational Index and Cortellis Drug Discovery Intelligence, visit here.

About VeriSIM Life

VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to improve drug discovery and development by significantly reducing the time and money it takes to bring a drug to market. BIOiSIM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. The platform predicts the likelihood of a candidate's success in clinical trials early in the preclinical stage, while reducing unnecessary experimentation and better informing key program decisions. For more information, visit www.verisimlife.com.

About Clarivate 

Clarivate is a leading global information services provider. We connect people and organizations to intelligence they can trust to transform their perspective, their work and our world. Our subscription and technology-based solutions are coupled with deep domain expertise and cover the areas of Academia & Government, Life Sciences & Healthcare and Intellectual Property. For more information, please visit www.clarivate.com. 

¹ US Food and Drug Administration. Speech to the Regulatory Affairs Professionals Society (RAPS) 2017 Regulatory Conference. September 2017. https://www.fda.gov/news-events/speeches-fda-officials/speech-regulatory-affairs-professionals-society-raps-2017-regulatory-conference-09112017 

Media Contact:  
Luna Ivkovic 
External Communications, Life Sciences & Healthcare 
[e-mail] 

Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-expands-partnership-with-verisim-life-to-accelerate-and-de-risk-research-and-drug-development-302004721.html

The Clarivate Stock at the time of publication of the news with a raise of 0,00 % to 7,40EUR on Tradegate stock exchange (04. Dezember 2023, 22:26 Uhr).